Navigation Links
Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
Date:12/19/2011

HOLLYWOOD, Calif., Dec. 19, 2011 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com) today announced their newly appointed officers and directors after their acquisition of Prescription Vending Machines, Inc. (PVM).

PVM's Founder and CEO, Vincent Mehdizadeh, commented on his fellow appointees by stating, "I am thrilled to have such dynamic individuals on our team, which are comprised of Doctorates and MBAs. We are entering a period of rapid growth and the expertise of this team will help steer the company, set important policies, and establish a solid foundation that will support our expansion from a mid-size company to an international leader in our field." Mr. Mehdizadeh went on to state, "Since PVM is a profitable company with a solid management team, we wanted to implement PVM's officers in key positions within Medbox, Inc."

Effective December 1, 2011, the new Executive Management Team for Medbox, Inc. is as follows:

Vincent Mehdizadeh, Board Member (CEO and Founder, PVM)
Dr. Bruce Bedrick, President, Director, Board Member (COO, PVM)
Leila Guieb, Treasurer, Director, Board Member (CFO, PVM)
Christine Collins, Secretary, Director
Angelique Dolan, Board Member (Director of Marketing, PVM)

For more information on Medbox, Inc. please call the Investor Relations Department at (800) 766-1452 or go online to www.medboxinc.com

Medbox is a publicly traded company, with its stock listed on the OTC Board, ticker symbol MDBX.

About Medbox: 
Medbox is a leader in the development, sales and service of automated, biometrically controlled, dispensing and storage systems for medicine. The company also features automated, biometrically controlled, mini-storage units for other valuables. Medbox has offices throughout the world, including New York, Tokyo, Toronto, with corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, clinics, hospitals, and medical groups worldwide.

 

 


'/>"/>
SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Biophysical Society announces speakers for Future of Biophysics Burroughs Wellcome Fund Symposium
2. Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference
3. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
4. Biophysical Society Announces winners of 2012 International Relations Committee travel awards
5. Biophysical Society announces winners of 2012 CPOW travel awards
6. EpiGen announces collaboration with Nestlé
7. Minister announces UK-India collaboration on bioenergy
8. BGI announces collaborative research agreements with Oregon State University
9. NIH TRND program announces next round of drug development projects
10. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
11. BGI announces collaboration with Johns Hopkins University on synthetic yeast project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology: